Biomedical Engineering Reference
In-Depth Information
76. Johnson VG, Wrobel C, Wilson D, Zovickian J, Greenfield L,
Oldfield EH, et al. (1989) Improved tumor-specific immuno-
toxins in the treatment of CNS and leptomeningeal neoplasia.
J. Neurosurg. 70, 240-248.
77. Hall WA, Godal A, Juell S, Fodstad O. (1992) In vitro efficacy
of transferrin-toxin conjugates against glioblastoma multi-
forme. J. Neurosurg. 76, 838-844.
78. Martell LA, Agrawal A, Ross DA, Muraszko KM. (1993)
Efficacy of transferring receptor-targeted immunotoxins in
brain tumor cell lines and pediatric brain tumors. Cancer
Res . 53, 1348-1353.
79. Chignola R, Foroni R, Candiani C, Franceschi A, Pasti M,
Stevanoni G, et al. (1994) Cytoreductive effects of anti-trans-
ferrin receptor immunotoxin in a multicellular tumor spheroid
model. Int. J. Cancer 57, 268-274.
80. Laske DW, Ilercil O, Akbasak A, Youle RJ, Oldfield EH.
(1994) Efficacy of direct intratumoral therapy with targeted
protein
in pati ents w ith malignant br ai n tumors. Nat. Med. 3,
136 2-136 8.
83. Weaver M, Laske DW. (2003) Transferrin receptor ligand-
targeted toxin conjugate (Tf-CRM107) for therapy of malig-
nant gliomas. J. Neurooncol. 65, 3-13.
84. http://clinicaltrials.gov, study identifier NCT00083447, s. also
NCT00088400 and NCT00087230. Last accessed on Oct.
28th, 2012.
85. http://www.drugs.com/news/celtic-pharma-terminates-trans-
mid-trial-ksb311r-ciii-001-5246.html. Last accessed on Oct.
28th, 2012.
86. Puri RK. (2003) Introduction to special issue: targeted toxins
for glioma therapy. J. Neurooncol. 65, 1-2.
87. Pastan I, Kreitman RJ. (1998) Immunotoxins for targeted
cancer therapy. Adv. Drug Deliv. Rev. 31, 53-88.
88. Briellmann RS, Pell GS, Wellard RM, Mitchell LA, Abbott DF,
Jackson GD. (2003) MR imaging of epilepsy: state of the art at
1.5 T and potential of 3 T. Epileptic Disord. 5, 3-20.
89. Tummala RP, Chu RM, Liu H, Truwit CL, Hall WA. (2003)
Application of diffusion tensor imaging to magnetic-resonance-
guided brain tumor resection. Pediatr. Neurosurg. 39, 39-43.
90. Cruz Junior LC, Sorensen AG. (2005) Diffusion tensor mag-
netic resonance imaging of brain tumors. Neurosurg. Clin. N.
Am. 16, 115-134.
toxins for solid human gliomas
in nude mice. J.
Neurosurg. 80, 520-526.
81. Engebraaten O, Hjortland GO, Juell S, Hirschberg H, Fodstad
O. (2002) Intratumoral immunotoxin treatment of human
malignant brain tumors in immunodeficient animals. Int. J.
Cancer 97, 846-852.
82. Laske , DW, Youle RJ, Oldfield EH. (1997 ) Tumor r eg ress ion
w ith regional di st ribut ion of t he targeted toxin TF-C RM10 7
Search WWH ::
Custom Search